BE837265A - Nouveaux acides delta2,3 - 1,4 - morpholino - 2 - carboxyliques substitues, leur procede de synthese et medicament les contenant - Google Patents

Nouveaux acides delta2,3 - 1,4 - morpholino - 2 - carboxyliques substitues, leur procede de synthese et medicament les contenant

Info

Publication number
BE837265A
BE837265A BE163273A BE163273A BE837265A BE 837265 A BE837265 A BE 837265A BE 163273 A BE163273 A BE 163273A BE 163273 A BE163273 A BE 163273A BE 837265 A BE837265 A BE 837265A
Authority
BE
Belgium
Prior art keywords
delta2
morpholino
carboxylic
new
product containing
Prior art date
Application number
BE163273A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE837265A publication Critical patent/BE837265A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
BE163273A 1975-01-02 1975-12-31 Nouveaux acides delta2,3 - 1,4 - morpholino - 2 - carboxyliques substitues, leur procede de synthese et medicament les contenant BE837265A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/538,271 US4012383A (en) 1975-01-02 1975-01-02 Δ2,3 -1,4-morpholine-2-carboxylic acids and derivatives thereof useful in preparation of antibacteria agents

Publications (1)

Publication Number Publication Date
BE837265A true BE837265A (fr) 1976-06-30

Family

ID=24146199

Family Applications (1)

Application Number Title Priority Date Filing Date
BE163273A BE837265A (fr) 1975-01-02 1975-12-31 Nouveaux acides delta2,3 - 1,4 - morpholino - 2 - carboxyliques substitues, leur procede de synthese et medicament les contenant

Country Status (7)

Country Link
US (4) US4012383A (fr)
JP (3) JPS613790B2 (fr)
BE (1) BE837265A (fr)
CA (2) CA1095041A (fr)
DE (1) DE2600039A1 (fr)
FR (1) FR2296423A1 (fr)
GB (1) GB1538240A (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172199A (en) * 1975-01-02 1979-10-23 Bristol-Myers Company O-2-isocephem-4-carboxylic acid derivatives as antibacterial agents
US4011216A (en) * 1975-04-11 1977-03-08 Bristol-Myers Company Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents
US4013648A (en) * 1975-07-23 1977-03-22 Bristol-Myers Company Δ2,3 -0-2-Isocephem-4-carboxylic acid and derivatives as antibacterial agents
US4171438A (en) * 1975-07-23 1979-10-16 Bristol-Myers Company 0-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents
AU516665B2 (en) * 1975-10-06 1981-06-18 Fujisawa Pharmaceutical Co., Ltd 2-azetidone compounds
US4162250A (en) * 1976-09-08 1979-07-24 Smithkline Corporation 3-Aminoazetidinone derivatives
US4089956A (en) * 1976-09-08 1978-05-16 Smithkline Corporation 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof
FR2380221A1 (fr) * 1977-02-11 1978-09-08 Ugine Kuhlmann Perfectionnement au procede de preparation du percarbonate de sodium
DE2967053D1 (en) * 1978-09-12 1984-07-19 Fujisawa Pharmaceutical Co Starting compounds for preparing cephem compounds and processes for their preparation
JPH02111750A (ja) * 1978-09-12 1990-04-24 Fujisawa Pharmaceut Co Ltd 酪酸誘導体
DK389080A (da) * 1979-09-13 1981-03-14 Kyowa Hakko Kogyo Kk Fremgangsmaade til fremstilling af racemiske eller optisk aktive cephalosporin-analoge carbacephemforbindelser eller farmaceutisk accepable salte deraf
US4663450A (en) * 1979-10-25 1987-05-05 Kyowa Hakko Kogyo Co., Ltd. Optically active cephalosporin analogs
FR2505840A1 (fr) * 1981-05-13 1982-11-19 Roussel Uclaf Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments
JPS58192866A (ja) * 1982-04-30 1983-11-10 Kanegafuchi Chem Ind Co Ltd 2―アゼチジノン誘導体
CA1204746A (fr) * 1982-08-19 1986-05-20 Hoffmann-La Roche Limited Beta-lactams
JP2525170B2 (ja) * 1987-03-09 1996-08-14 大塚製薬株式会社 2―オキサイソセフェム誘導体の製造方法
US8593825B2 (en) * 2009-10-14 2013-11-26 Wintec Industries, Inc. Apparatus and method for vertically-structured passive components
CN103508969A (zh) * 2013-09-09 2014-01-15 南通市华峰化工有限责任公司 一种高纯度5-四氮唑乙酸的合成生产方法
EP3055295A1 (fr) * 2013-10-10 2016-08-17 Merck Patent GmbH Synthèse d'ester d'acide 1-alkyl-2-amino-imidazol-5-carboxylique utilisant des dérivés d'ester de n-alkyle-glycine substitués par calpha
CN114345304A (zh) * 2021-12-30 2022-04-15 北京建工环境修复股份有限公司 一种负载零价铁的纤维素壳聚糖复合微球及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1914366A1 (de) * 1969-03-21 1970-10-01 Bayer Ag Arzneimittel auf Basis neuer,heterocyclischer Verbindungen
CH541576A (de) * 1970-11-03 1973-09-15 Ciba Geigy Ag Verfahren zur Herstellung thiaheterocyclischer Verbindungen
DE2219601A1 (de) 1971-04-27 1972-11-16 Astra Läkemedel AB, Södertälje (Schweden) beta-Lactame und Verfahren zu deren Herstellung
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US4011216A (en) * 1975-04-11 1977-03-08 Bristol-Myers Company Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents
US4136648A (en) * 1976-12-22 1979-01-30 Ford Motor Company Low weight reciprocating engine

Also Published As

Publication number Publication date
US4113946A (en) 1978-09-12
FR2296423A1 (fr) 1976-07-30
JPS61197586A (ja) 1986-09-01
JPS613790B2 (fr) 1986-02-04
GB1538240A (en) 1979-01-17
DE2600039A1 (de) 1976-12-02
JPS6229434B2 (fr) 1987-06-25
CA1095041A (fr) 1981-02-03
US4012383A (en) 1977-03-15
CA1109873A (fr) 1981-09-29
US4066831A (en) 1978-01-03
JPS5191293A (fr) 1976-08-10
FR2296423B1 (fr) 1978-09-22
US4065623A (en) 1977-12-27
JPS6229435B2 (fr) 1987-06-25
JPS61197587A (ja) 1986-09-01

Similar Documents

Publication Publication Date Title
BE837265A (fr) Nouveaux acides delta2,3 - 1,4 - morpholino - 2 - carboxyliques substitues, leur procede de synthese et medicament les contenant
BE827354A (fr) Nouveaux derives benzamidiques de pyrrolidine et piperidine, leur procede de preparation et medicament les contenant
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
FR2318637A1 (fr) Nouveaux acides morpholine-carboxyliques, leur synthese et medicament les contenant
BE827777A (fr) Nouveaux amides d'acides carboxyliques, leur procede de preparation et medicament les contenant
FR2274294A1 (fr) Nouveaux amides d'acides carboxyliques, leur procede de preparation et medicament les contenant
BE826900A (fr) Nouveaux derives 1-(4-phenoxy-phenyl)-1,3,5 triaziniques, leur triaziniques procede de preparation et medicament les contenant
BE820147A (fr) Nouveaux derives amines de sucres, leur procede de preparation et medicament les contenant
BE874135A (fr) Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant
BE855713Q (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et medicament les contenant
FR2307543A1 (fr) Nouveaux amides peptidiques, leur procede de preparation et medicament les contenant
FR2287916A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et medicament les contenant
BE868943A (fr) Nouveaux 3-indolyl-tertiobutylaminopropanols, leur procede de production et medicament les contenant
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
BE876297A (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
BE842842A (fr) Nouveaux derives pyrazoliques substitues en position 1, leur procede de preparation et medicament les contenant
FR2290897A1 (fr) Nouveaux derives d'aminopropanol, leur procede de preparation et des medicaments les contenant
BE789138A (fr) Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant
BE861697A (fr) Nouveaux antibiotiques polycycliques, leur procede de preparation et medicament les contenant
BE858781A (fr) Nouveaux derives 1,4-dihydropyridiques de sucres, leur procede de preparation et medicament les contenant
BE860709A (fr) Nouveaux derives substitues de 0-phenylenediamine, leur procede de preparation et medicament les contenant
BE805210A (fr) Nouveaux amides d'acides imidazoiylacetiques, leur procede de preparation et medicaments les contenant
BE799144A (fr) Nouveaux acylamino acides, leur procede d'obtention et les compositions pharmaceutiques en renfermant
BE835953A (fr) Nouveaux diaryloxy - imidazolyl - o,n - acetals, leur procede de preparation et medicament les contenant
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL MYERS CANADA LTD

Effective date: 19911231